IN2014CN02169A - - Google Patents

Download PDF

Info

Publication number
IN2014CN02169A
IN2014CN02169A IN2169CHN2014A IN2014CN02169A IN 2014CN02169 A IN2014CN02169 A IN 2014CN02169A IN 2169CHN2014 A IN2169CHN2014 A IN 2169CHN2014A IN 2014CN02169 A IN2014CN02169 A IN 2014CN02169A
Authority
IN
India
Prior art keywords
present
azulenes
dysmenorrhea
vasopressin
oxa
Prior art date
Application number
Other languages
English (en)
Inventor
Cosimo Dolente
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IN2014CN02169A publication Critical patent/IN2014CN02169A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN2169CHN2014 2011-09-26 2012-09-24 IN2014CN02169A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11182796 2011-09-26
PCT/EP2012/068721 WO2013045373A1 (en) 2011-09-26 2012-09-24 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists

Publications (1)

Publication Number Publication Date
IN2014CN02169A true IN2014CN02169A (pt) 2015-05-29

Family

ID=46881068

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2169CHN2014 IN2014CN02169A (pt) 2011-09-26 2012-09-24

Country Status (22)

Country Link
US (1) US8828989B2 (pt)
EP (1) EP2760871B1 (pt)
JP (1) JP5909554B2 (pt)
KR (1) KR101682777B1 (pt)
CN (1) CN103827121B (pt)
AR (1) AR087999A1 (pt)
AU (1) AU2012314593B2 (pt)
BR (1) BR112014006945A2 (pt)
CA (1) CA2844581A1 (pt)
CL (1) CL2014000717A1 (pt)
CO (1) CO6870036A2 (pt)
CR (1) CR20140092A (pt)
EA (1) EA024990B1 (pt)
EC (1) ECSP14013271A (pt)
IN (1) IN2014CN02169A (pt)
MA (1) MA35535B1 (pt)
MX (1) MX2014003643A (pt)
PE (1) PE20141397A1 (pt)
SG (1) SG2014010607A (pt)
TW (1) TWI553013B (pt)
UA (1) UA111623C2 (pt)
WO (1) WO2013045373A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102069T2 (tr) 1999-01-19 2001-11-21 Ortho-Mcneil Pharmaceutical, Inc. Vasopresin reseptörü antagonistleri olarak trisiklik benzodiazepinler.
US6765004B1 (en) 1999-06-17 2004-07-20 Ortho-Mcneil Pharmaceutical, Inc. Indoloazepines as vasopressin receptor antagonists
GB0303852D0 (en) * 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
US7119088B2 (en) 2003-02-19 2006-10-10 Pfizer Inc. Triazole compounds useful in therapy
GB0400700D0 (en) * 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
CA2578370A1 (en) * 2004-08-25 2006-03-02 Pfizer Inc. Triazolobenzodiazepines and their use as vasopressin antagonists
MX2011005119A (es) 2008-11-18 2011-05-30 Hoffmann La Roche Alquilciclohexileteres de dihidrotetraazabenzoazulenos.
BRPI0922303B1 (pt) 2008-11-28 2019-11-12 Hoffmann La Roche arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos, seu processo de preparação, composição farmacêutica que os compreende e uso

Also Published As

Publication number Publication date
EA201490558A1 (ru) 2014-06-30
CA2844581A1 (en) 2013-04-04
AR087999A1 (es) 2014-04-30
BR112014006945A2 (pt) 2017-04-04
KR20140079790A (ko) 2014-06-27
CL2014000717A1 (es) 2014-10-03
JP2014527993A (ja) 2014-10-23
CR20140092A (es) 2014-03-20
EP2760871B1 (en) 2018-07-18
CN103827121B (zh) 2016-08-03
WO2013045373A1 (en) 2013-04-04
PE20141397A1 (es) 2014-10-13
NZ620653A (en) 2016-03-31
AU2012314593A8 (en) 2014-03-27
MX2014003643A (es) 2014-04-30
SG2014010607A (en) 2014-05-29
CN103827121A (zh) 2014-05-28
US20130079333A1 (en) 2013-03-28
EP2760871A1 (en) 2014-08-06
KR101682777B1 (ko) 2016-12-05
CO6870036A2 (es) 2014-02-20
US8828989B2 (en) 2014-09-09
TW201315737A (zh) 2013-04-16
JP5909554B2 (ja) 2016-04-26
AU2012314593A1 (en) 2014-02-20
TWI553013B (zh) 2016-10-11
UA111623C2 (uk) 2016-05-25
ECSP14013271A (es) 2014-05-31
MA35535B1 (fr) 2014-10-02
AU2012314593B2 (en) 2016-09-29
EA024990B1 (ru) 2016-11-30

Similar Documents

Publication Publication Date Title
NZ603223A (en) Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
MY160457A (en) Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin via receptor antagonists
MX2014003600A (es) Ciclohexil-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenos como antagonistas v1a.
MY160977A (en) Heterobiaryl-cyclohexyl-tetraazabenzo[e] azulenes
CO6341478A2 (es) Arilciclohexileteres de dihidro-tetraazabenzoazulenos para su uso como antagonistas del receptor v1a de vasopresina
BR112012024306A2 (pt) aril-cicloexil-tetraazabenzo[e] azulenos
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
IN2014CN02515A (pt)
TW200734343A (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IN2014DN09804A (pt)
BR112012025942A2 (pt) aril-/heteroaril-ciclo-hexenil-tetra-azabenzo[e]azulenos como antagonistas de vasopressina
PH12016500919A1 (en) Spiro-oxazolones
MX2016009501A (es) Espiro-oxazolonas.
IN2014CN02169A (pt)
PH12017500891A1 (en) Spiro-thiazolones